Genetics of Hyperparathyroidism, Including Parathyroid Cancer
- PMID: 28476229
- PMCID: PMC5424626
- DOI: 10.1016/j.ecl.2017.01.006
Genetics of Hyperparathyroidism, Including Parathyroid Cancer
Abstract
Primary hyperparathyroidism (HPT) is a metabolic disease caused by the excessive secretion of parathyroid hormone from 1 or more neoplastic parathyroid glands. HPT is largely sporadic, but it can be associated with a familial syndrome. The study of such families led to the discovery of tumor suppressor genes whose loss of function is now recognized to underlie the development of many sporadic parathyroid tumors. Heritable and acquired oncogenes causing parathyroid neoplasia are also known. Studies of somatic changes in parathyroid tumor DNA and investigation of kindreds with unexplained familial HPT promise to unmask more genes relevant to parathyroid neoplasia.
Keywords: CCND1; CDC73; MEN1; MEN2A; Multiple endocrine neoplasia; Oncogene; RET; Tumor suppressor.
Published by Elsevier Inc.
Conflict of interest statement
Figures
References
-
- Brown EM, Pollak M, Seidman CE, et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med. 1995;333(4):234–240. - PubMed
-
- Brown EM. Role of the calcium-sensing receptor in extracellular calcium homeostasis. Best Pract Res Clin Endocrinol Metab. 2013;27(3):333–343. - PubMed
-
- Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–158. - PubMed
-
- Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer. 2005;5(5):367–375. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
